Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03277209
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas

Who this might be right for
Pancreas Cancer
Weill Medical College of Cornell University 2
Testing effectiveness (Phase 2)Study completedNCT00258232
What this trial is testing

Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Not applicableEnded earlyNCT00608595
What this trial is testing

Celecoxib in Treating Patients With Early-Stage Rectal Cancer

Who this might be right for
Colorectal Cancer
Vanderbilt-Ingram Cancer Center 10
Not applicableLooking for participantsNCT04739072
What this trial is testing

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

Who this might be right for
Colorectal AdenocarcinomaStage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8+11 more
M.D. Anderson Cancer Center 1,000
Not applicableStudy completedNCT03794128
What this trial is testing

Personalized Neoantigen Cancer Vaccines

Who this might be right for
Non Small Cell Lung CancerColorectal CancerGastroesophageal Adenocarcinoma+2 more
Gritstone bio, Inc. 93
Testing effectiveness (Phase 2)Study completedNCT00307736
What this trial is testing

Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerAdenocarcinoma of the Rectum
Massachusetts General Hospital 32
Early research (Phase 1)Study completedNCT00574977
What this trial is testing

Safety Study of Modified Vaccinia Virus to Cancer

Who this might be right for
MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more
David Bartlett 26
Early research (Phase 1)Study completedNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Early research (Phase 1)Study completedNCT03798626
What this trial is testing

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Who this might be right for
Colorectal CancerGastroesophageal CancerRenal Cell Carcinoma
Novartis Pharmaceuticals 167
Testing effectiveness (Phase 2)Ended earlyNCT00002796
What this trial is testing

Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+7 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT06108596
What this trial is testing

Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail

Who this might be right for
Locally Advanced Rectal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 33
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Large-scale testing (Phase 3)Study completedNCT00004885
What this trial is testing

Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 430
Testing effectiveness (Phase 2)WithdrawnNCT00503932
What this trial is testing

Proton Therapy With Capecitabine for Rectal Cancer

Who this might be right for
Rectal Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT04526314
What this trial is testing

Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older

Who this might be right for
Colon Adenocarcinoma
Registre des Tumeurs Digestives du Finistère 308
Not applicableStudy completedNCT05384184
What this trial is testing

Next Generation " Pre-clinical Model for Colorectal Cancer Metastases and Hepatocellular Carcinomas

Who this might be right for
Colorectal Cancer Metastases and Hepatocellular Carcinomas
Assistance Publique Hopitaux De Marseille 48
Not applicableEnded earlyNCT02363647
What this trial is testing

Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

Who this might be right for
Medullary Thyroid CancerColon Cancer
Icahn School of Medicine at Mount Sinai 10
Early research (Phase 1)Study completedNCT03894618
What this trial is testing

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more
Shattuck Labs, Inc. 49
Large-scale testing (Phase 3)UnknownNCT00003260
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 109
Not applicableStudy completedNCT06789224
What this trial is testing

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

Who this might be right for
Bladder CarcinomaProstate TumorGallbladder Carcinoma+9 more
Lindis Bloodcare GmbH 136
Next Page